Haploidentical Stem Cell Transplantation

The supplement covers work of leading investigators presented in the 9th international symposium on haploidentical hematopoietic stem cell transplantation (Haplo-HSCT). These include outcomes of T cell depleted and T cell replete Haplo-HSCT, new strategies for enhancing immune reconstitution as well as advances in CAR therapies and in immune tolerance induction as a prelude for organ transplantation.

Publication of this supplement was sponsored by Gilead Sciences Europe Ltd, Cell Source, Inc., The Chorafas Institute for Scientific Exchange of the Weizmann Institute of Science, Kiadis Pharma, Miltenyi Biotec, Celgene, Centro Servizi Congressuali, Almog Diagnostic.